Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2012


4th World Epigenetics Summit

04 Dec 2012 - 06 Dec 2012 - London, UK



Bookmark and Share


The 4th World Epigenetics Summit provides a unique platform on which senior representatives from GSK, Constellation and Epizyme share ideas with leading academic figures such as Tony Kouzarides and Chas Bountra. In bringing together the minds behind the most exciting drugs in development, the meeting represents two days dedicated to overcoming the most pressing challenges in epigenetic drug development.

Why attend?

Get an up-to-the-minute snapshot of the very latest epigenetic target classes for disease therapy from Epizyme, GSK and Constellation Pharmaceuticals

 Learn how the SGC are driving innovation by open source chemical probe design

 Discover the excitement that epigenetic drugs are generating in the clinic with 4SC

 Explore the potential of epigenetic modulation in non-oncological disease indications with GSK

Get excited at the potential of RNA therapeutics in a range of disease indications with RaNA Therapeutics

Find out how to optimize methods, assays and practices throughout the production pipeline so you can maximize the value of your R&D spend




Further information
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!